Nitec licenses Lodotra to Mundipharma in Europe
This article was originally published in Scrip
Executive Summary
Nitec Pharma has granted Mundipharma an exclusive licence to distribute Lodotra (prednisone) in Europe excluding Germany and Austria, where it is licensed to Merck Serono. The drug, in co-development with SkyePharma, received EU approval for rheumatoid arthritis and associated morning stiffness in January (scripnews.com, January 7th, 2009).